Immunization of man against rubella. Discussion on sessions 3 and IV.
D000293:Adolescent; D000328:Adult; D000818:Animals; D000906:Antibodies / Q000032:analysis; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D005260:Female; D000882:Haplorhini; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008198:Lymph Nodes / Q000382:microbiology; D008297:Male; D008431:Maternal-Fetal Exchange; D009305:Nasopharynx / Q000382:microbiology; D010919:Placebos; D011247:Pregnancy; D012137:Respiratory System / Q000382:microbiology; D012409:Rubella / Q000276:immunology / Q000517:prevention & control*; D012411:Rubella Vaccine / Q000009:adverse effects; D012412:Rubella virus / Q000302:isolation & purification; D013154:Spleen / Q000382:microbiology; D013557:Switzerland; D014420:Turbinates / Q000382:microbiology; D014611:Vaccination
D000906:Antibodies; D010919:Placebos; D012411:Rubella Vaccine